Haverford Trust CO Eli Lilly & CO Transaction History

Haverford Trust CO

  • $10.2 Billion
  • Q3 2024

A detailed history of Haverford Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Haverford Trust CO holds 3,515 shares of LLY stock, worth $2.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,515
Previous 3,484 0.89%
Holding current value
$2.8 Million
Previous $3.15 Million 1.27%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$772.14 - $960.02 $23,936 - $29,760
31 Added 0.89%
3,515 $3.11 Million
Q2 2024

Aug 13, 2024
SELL
$724.87 - $909.04 $977,849 - $1.23 Million
-1,349 Reduced 27.91%
3,484 $3.15 Million
Q1 2024

May 02, 2024
SELL
$592.2 - $792.28 $592 - $792
-1 Reduced 0.02%
4,833 $3.76 Million
Q4 2023

Feb 08, 2024
SELL
$525.19 - $619.13 $758,899 - $894,642
-1,445 Reduced 23.01%
4,834 $2.82 Million
Q3 2023

Nov 09, 2023
SELL
$434.7 - $599.3 $72,160 - $99,483
-166 Reduced 2.58%
6,279 $3.37 Million
Q2 2023

Aug 08, 2023
BUY
$350.74 - $468.98 $127,669 - $170,708
364 Added 5.99%
6,445 $3.02 Million
Q1 2023

May 12, 2023
SELL
$310.63 - $364.82 $46,594 - $54,723
-150 Reduced 2.41%
6,081 $2.09 Million
Q4 2022

Feb 13, 2023
SELL
$321.55 - $374.67 $211,901 - $246,907
-659 Reduced 9.56%
6,231 $2.28 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $26,683 - $30,408
90 Added 1.32%
6,890 $2.23 Million
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $194,832 - $228,761
699 Added 11.46%
6,800 $2.21 Million
Q1 2022

May 05, 2022
BUY
$234.69 - $291.66 $331,616 - $412,115
1,413 Added 30.14%
6,101 $1.75 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $66,780 - $82,874
297 Added 6.76%
4,688 $1.3 Million
Q3 2021

Nov 12, 2021
BUY
$221.6 - $272.71 $110,800 - $136,355
500 Added 12.85%
4,391 $1.02 Million
Q2 2021

Aug 16, 2021
SELL
$180.55 - $233.54 $559,524 - $723,740
-3,099 Reduced 77.63%
893 $893,000
Q2 2021

Aug 16, 2021
BUY
$180.55 - $233.54 $541,288 - $700,152
2,998 Added 335.72%
3,891 $893,000
Q1 2021

May 12, 2021
SELL
$164.32 - $212.72 $3,615 - $4,679
-22 Reduced 0.55%
3,992 $746,000
Q3 2020

Nov 10, 2020
BUY
$146.22 - $169.13 $111,565 - $129,046
763 Added 23.47%
4,014 $594,000
Q2 2020

Aug 13, 2020
BUY
$136.42 - $164.18 $22,918 - $27,582
168 Added 5.45%
3,251 $534,000
Q1 2020

May 11, 2020
SELL
$119.05 - $147.35 $363,102 - $449,417
-3,050 Reduced 49.73%
3,083 $428,000
Q4 2019

Feb 10, 2020
BUY
$106.92 - $132.43 $135,039 - $167,259
1,263 Added 25.93%
6,133 $806,000
Q3 2019

Nov 04, 2019
SELL
$106.79 - $116.16 $165,310 - $179,815
-1,548 Reduced 24.12%
4,870 $545,000
Q2 2019

Aug 13, 2019
BUY
$110.79 - $129.32 $267,447 - $312,178
2,414 Added 60.29%
6,418 $711,000
Q1 2019

May 09, 2019
SELL
$111.31 - $131.02 $38,624 - $45,463
-347 Reduced 7.98%
4,004 $520,000
Q4 2018

Feb 12, 2019
SELL
$105.9 - $118.64 $86,308 - $96,691
-815 Reduced 15.78%
4,351 $503,000
Q3 2018

Nov 08, 2018
BUY
$85.86 - $107.31 $14,166 - $17,706
165 Added 3.3%
5,166 $554,000
Q2 2018

Aug 10, 2018
SELL
$75.7 - $86.88 $18,925 - $21,720
-250 Reduced 4.76%
5,001 $427,000
Q1 2018

May 09, 2018
SELL
$74.21 - $87.6 $63,375 - $74,810
-854 Reduced 13.99%
5,251 $406,000
Q4 2017

Feb 13, 2018
BUY
$81.94 - $87.89 $69,976 - $75,058
854 Added 16.26%
6,105 $516,000
Q3 2017

Nov 09, 2017
SELL
$77.07 - $85.54 $34,219 - $37,979
-444 Reduced 7.8%
5,251 $449,000
Q2 2017

Aug 14, 2017
BUY
N/A
5,695
5,695 $469,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email